140 related articles for article (PubMed ID: 22815137)
1. Sorafenib combined with locoregional therapy prior to liver transplantation for hepatocellular carcinoma: an update on a previous case report.
Vagefi PA; Hirose R
J Gastrointest Cancer; 2013 Jun; 44(2):246-7. PubMed ID: 22815137
[No Abstract] [Full Text] [Related]
2. Sorafenib plus cisplatin for hepatocellular carcinoma.
Brower V
Lancet Oncol; 2016 Oct; 17(10):e424. PubMed ID: 27617663
[No Abstract] [Full Text] [Related]
3. Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.
Zavaglia C; Airoldi A; Mancuso A; Vangeli M; ViganĂ² R; Cordone G; Gentiluomo M; Belli LS
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):180-6. PubMed ID: 23044808
[TBL] [Abstract][Full Text] [Related]
4. Complete Regression of Recurrent Advanced Hepatocellular Carcinoma After Liver Transplantation in Response to Sorafenib Treatment: A Case Report.
Lee HY; Yang KH; Choi BH; Park YM; Yoon KT; Ryu JH; Chu CW
Transplant Proc; 2016; 48(1):247-50. PubMed ID: 26915876
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: sorafenib before liver transplantation?
Braillon A
Hepatology; 2010 Jun; 51(6):2232-3. PubMed ID: 20041410
[No Abstract] [Full Text] [Related]
6. Treating advanced hepatocellular carcinoma: How to get out of first gear.
Harding JJ; Abou-Alfa GK
Cancer; 2014 Oct; 120(20):3122-30. PubMed ID: 24898783
[TBL] [Abstract][Full Text] [Related]
7. Sustained remission over 36 months of advanced hepatocellular carcinoma after short-term sorafenib therapy.
Ahn SY; Lee HS; Kweon YO; Tak WY; Park SY
Dig Dis Sci; 2013 May; 58(5):1428-32. PubMed ID: 23306847
[No Abstract] [Full Text] [Related]
8. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
[TBL] [Abstract][Full Text] [Related]
9. [Current status and future perspective of sorafenib for advanced hepatocellular carcinoma].
Ikeda M; Mitsunaga S; Shimizu S; Ohno I; Takahashi H; Okuyama H; Kuwahara A; Okusaka T
Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1346-54. PubMed ID: 22863957
[No Abstract] [Full Text] [Related]
10. Tolerability of single-agent sorafenib in the treatment of elderly patients with hepatocellular carcinoma (HCC).
Francini E; Bianco V
Hepatology; 2014 Aug; 60(2):764-5. PubMed ID: 25187926
[No Abstract] [Full Text] [Related]
11. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
Liu Y; Yue H; Xu S; Wang F; Ma N; Li K; Qiao L; Wang J
Int J Clin Oncol; 2015 Oct; 20(5):952-9. PubMed ID: 25712158
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma.
Garuti F; Camelli V; Spinardi L; Bucci L; Trevisani F
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 27079903
[TBL] [Abstract][Full Text] [Related]
13. Quantification of dynamic contrast-enhanced ultrasound in HCC: prediction of response to a new combination therapy of sorafenib and panobinostat in advanced hepatocellular carcinoma.
Knieling F; Waldner MJ; Goertz RS; Strobel D
BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23257272
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.
Takeyama H; Beppu T; Higashi T; Kaida T; Arima K; Taki K; Imai K; Nitta H; Hayashi H; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Ishiko T; Tanaka M; Sasaki Y; Baba H
Surg Today; 2018 Apr; 48(4):431-438. PubMed ID: 29110089
[TBL] [Abstract][Full Text] [Related]
15. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.
Matsuda Y; Ichida T; Fukumoto M
Med Mol Morphol; 2011 Sep; 44(3):117-24. PubMed ID: 21922382
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib in advanced hepatocellular carcinoma.
Palmer DH
N Engl J Med; 2008 Dec; 359(23):2498; author reply 2498-9. PubMed ID: 19065750
[No Abstract] [Full Text] [Related]
18. Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma.
Xu L; Wang B; Ding W
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):e24-e25. PubMed ID: 28163072
[No Abstract] [Full Text] [Related]
19. AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
Altayar O; Shah R; Chang CY; Falck-Ytter Y; Muir AJ
Gastroenterology; 2022 Mar; 162(3):937-951. PubMed ID: 35210015
[No Abstract] [Full Text] [Related]
20. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma].
Yamashita T; Kaneko S
Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1335-45. PubMed ID: 22863956
[No Abstract] [Full Text] [Related]
[Next] [New Search]